Observational studyEuropean thyroid journal2026
Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers.
Edoardo Talpacci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.